Recombinant beta-serine-interferon in hairy cell leukemia compared prospectively with results with recombinant alpha-interferon.

@article{Glaspy1989RecombinantBI,
  title={Recombinant beta-serine-interferon in hairy cell leukemia compared prospectively with results with recombinant alpha-interferon.},
  author={John A. Glaspy and Stephen G. Marcus and Jan Ambersley and David W. Golde},
  journal={Cancer},
  year={1989},
  volume={64 2},
  pages={409-13}
}
Ten patients with hairy cell leukemia (HCL) requiring therapy were treated with recombinant beta-serine-interferon (rIFN-beta ser) (90 x 10(6) units [U] subcutaneously three times a week). Eight patients were evaluable for response and nine for toxicity. Five patients (63%) showed normalization of peripheral blood counts, and an additional two patients (25… CONTINUE READING